J3241 Injection. teprotumumab-trbw 10 milligrams
J-Codes
Also known as: teprotumumab, Tepezza, IGF-1 receptor inhibitor
Teprotumumab-trbw (Tepezza) 10 milligram injection is a human insulin-like growth factor-1 receptor inhibitor used for thyroid eye disease (Graves' ophthalmopathy).
Clinical Context
Indicated for thyroid eye disease (Graves' ophthalmopathy) to reduce proptosis and improve eye symptoms. Inhibits insulin-like growth factor-1 receptor signaling. Administered intravenously every 3 weeks for 8 weeks.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.